Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.73 - $2.73 $37,449 - $140,049
51,300 New
51,300 $120,000
Q2 2023

Aug 14, 2023

BUY
$2.49 - $20.59 $90,944 - $752,029
36,524 Added 41.55%
124,435 $335,000
Q1 2023

May 15, 2023

SELL
$15.95 - $25.18 $23,829 - $37,618
-1,494 Reduced 1.67%
87,911 $1.64 Million
Q4 2022

Feb 14, 2023

SELL
$13.27 - $17.73 $9,249 - $12,357
-697 Reduced 0.77%
89,405 $1.43 Million
Q3 2022

Nov 14, 2022

SELL
$11.4 - $14.6 $863,721 - $1.11 Million
-75,765 Reduced 45.68%
90,102 $1.17 Million
Q2 2022

Aug 15, 2022

BUY
$7.94 - $12.96 $104,545 - $170,644
13,167 Added 8.62%
165,867 $1.75 Million
Q1 2022

May 13, 2022

BUY
$12.02 - $16.79 $472,386 - $659,847
39,300 Added 34.66%
152,700 $1.84 Million
Q1 2021

May 17, 2021

SELL
$31.0 - $55.72 $158,100 - $284,172
-5,100 Reduced 4.3%
113,400 $3.94 Million
Q4 2020

Feb 03, 2021

SELL
$37.09 - $48.97 $548,932 - $724,756
-14,800 Reduced 11.1%
118,500 $4.4 Million
Q2 2020

Aug 12, 2020

BUY
$32.57 - $42.83 $394,097 - $518,243
12,100 Added 9.98%
133,300 $5.4 Million
Q1 2020

May 06, 2020

BUY
$23.3 - $45.96 $118,830 - $234,396
5,100 Added 4.39%
121,200 $4.21 Million
Q3 2019

Nov 12, 2019

BUY
$36.98 - $48.45 $207,087 - $271,320
5,600 Added 5.07%
116,100 $4.29 Million
Q2 2019

Aug 14, 2019

BUY
$35.13 - $55.53 $179,163 - $283,203
5,100 Added 4.84%
110,500 $4.99 Million
Q1 2019

May 13, 2019

BUY
$42.83 - $59.91 $1.21 Million - $1.69 Million
28,200 Added 36.53%
105,400 $5.73 Million
Q4 2018

Feb 11, 2019

BUY
$37.97 - $60.16 $41,767 - $66,176
1,100 Added 1.45%
77,200 $3.57 Million
Q2 2018

Aug 03, 2018

BUY
$44.9 - $64.95 $453,490 - $655,995
10,100 Added 15.3%
76,100 $4.76 Million
Q4 2017

Feb 08, 2018

BUY
$41.95 - $60.1 $922,900 - $1.32 Million
22,000 Added 50.0%
66,000 $3.13 Million
Q3 2017

Nov 01, 2017

BUY
$33.4 - $53.9 $1.47 Million - $2.37 Million
44,000
44,000 $2.37 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.